BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//TrialSonar//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:TrialSonar · $HLUN-B.CO readouts
X-WR-CALDESC:Clinical-trial primary completion dates from ClinicalTrials.go
 v\, refreshed nightly by TrialSonar. Not investment advice.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT04965675-pcd@trialsonar.netlify.app
DTSTAMP:20261118T125025Z
DTSTART;VALUE=DATE:20270326
DTEND;VALUE=DATE:20270327
SUMMARY:PROSPECT-2 readout (P3) · H. Lundbeck A/S $HLUN-B.CO
DESCRIPTION:A Study With Eptinezumab in Adolescents (12-17 Years) With Chro
 nic Migraine\n\nPrimary completion date: 2027-03-26 (estimated)\nOriginall
 y planned: 2024-10-01 (+29.8 months)\nPhase 3 · Neuro · Chronic Migraine
  in Children\nEnrollment: 285 · Sites: 79\n\nPrimary completion = last pa
 rticipant's primary-endpoint data collected\; topline results usually foll
 ow weeks to months later. Sponsor-reported\, often an estimate. Not invest
 ment advice.\n\nhttps://datacutoff.com/radar.html?nct=NCT04965675\
 nhttps://clinicaltrials.gov/study/NCT04965675
URL:https://datacutoff.com/radar.html?nct=NCT04965675
CATEGORIES:Neuro,Phase 3
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT05897320-pcd@trialsonar.netlify.app
DTSTAMP:20261118T125025Z
DTSTART;VALUE=DATE:20270706
DTEND;VALUE=DATE:20270707
SUMMARY:PROSPECT-1 readout (P3) · H. Lundbeck A/S $HLUN-B.CO
DESCRIPTION:A Study of Eptinezumab in Pediatric Participants With Episodic 
 Migraine\n\nPrimary completion date: 2027-07-06 (estimated)\nOriginally pl
 anned: 2024-10-31 (+32.1 months)\nPhase 3 · Neuro · Episodic Migraine\nE
 nrollment: 315 · Sites: 60\n\nPrimary completion = last participant's pri
 mary-endpoint data collected\; topline results usually follow weeks to mon
 ths later. Sponsor-reported\, often an estimate. Not investment advice.\n\
 nhttps://datacutoff.com/radar.html?nct=NCT05897320\nhttps://clinic
 altrials.gov/study/NCT05897320
URL:https://datacutoff.com/radar.html?nct=NCT05897320
CATEGORIES:Neuro,Phase 3
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT06471829-pcd@trialsonar.netlify.app
DTSTAMP:20261118T125025Z
DTSTART;VALUE=DATE:20270810
DTEND;VALUE=DATE:20270811
SUMMARY:BalanCeD readout (P2) · H. Lundbeck A/S $HLUN-B.CO
DESCRIPTION:A Trial of Lu AG13909 in Adult Participants With Cushing's Dise
 ase\n\nPrimary completion date: 2027-08-10 (estimated)\nOriginally planned
 : 2026-02-07 (+18.0 months)\nPhase 2 · Cardio-Met · Cushing's Disease\nE
 nrollment: 16 · Sites: 27\n\nPrimary completion = last participant's prim
 ary-endpoint data collected\; topline results usually follow weeks to mont
 hs later. Sponsor-reported\, often an estimate. Not investment advice.\n\n
 https://datacutoff.com/radar.html?nct=NCT06471829\nhttps://clinica
 ltrials.gov/study/NCT06471829
URL:https://datacutoff.com/radar.html?nct=NCT06471829
CATEGORIES:Cardio-Met,Phase 2
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
